Monkeypox treatment trial begins in the Democratic Republic of the Congo

NIH partnering with INRB to evaluate tecovirimat (TPOXX).

CDC in the Democratic Republic of the Congo, Global Health

Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo

Benjamin Ryan on X: NIH is gearing up to make a formal announcement about the US-based clinical trial for #TPOXX to treat #monkeypox, an NIH rep told me today. They are also

359 Monkeypox with Dr. Boghuma Titanji - The Curbsiders

A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Monkeypox is a new global threat. African scientists know what the world is up against, Science

Sickness, death surpass official count in DRC monkeypox outbreak, Health

Monkeypox

Clinical characterization of human monkeypox infections in the Democratic Republic of the Congo

Monkeypox in pregnancy: virology, clinical presentation, and obstetric management - American Journal of Obstetrics & Gynecology

Exclusive: Manufacturer Of World's Only Monkeypox Drug Says There's No Shortage; Will Work With WHO On Supplies To LMICs - Health Policy Watch

Clinical trials could get monkeypox drug to desperate patients, but U.S. efforts lag

Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission - ScienceDirect